Compare Immunovant Inc. Common Stock (IMVT) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Upwork Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.47 (market cap $6.25B), while Upwork Inc trades at $8.6 (market cap $1.07B). The key difference: Immunovant Inc. Common Stock is far larger — about 5.8× Upwork Inc's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Upwork Inc for 38 Days on average.
| IMVT | UPWK | |
|---|---|---|
Market Cap | $6.25B | $1.07B |
Volume | 1,755,411 | 2,574,130 |
Sector | Health | Industrials |
52-Week High | $44.96 | $22.11 |
52-Week Low | $17.03 | $7.84 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $5.35B | $833.01M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UPWK trades at $8.57, up 2.02% today, with a bearish technical signal from moving averages and RSI near overbought levels. The company reported mixed Q2 2026 earnings, beating EPS estimates but missing on revenue guidance, leading to a recent stock decline. Fundamentals show strong profitability with a 77.21% gross margin and 12.93% net income margin, while valuation ratios like P/E of 10.99 and P/S of 1.48 appear reasonable. Recent news highlights insider selling and ongoing securities fraud investigations.
The outlook for UPWK is cautious due to AI-driven competitive threats and weak guidance, though low valuation provides downside protection. Risks include declining active clients and legal scrutiny, but analyst consensus remains bullish with a $9.64 price target. Investment opportunity hinges on execution amid industry disruption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
